LRP6 and fatty liver disease: Additionally, mice carrying the loss-of-function mutation LRP6 p.R611C develop fatty liver disease including insulin resistance, liver inflammation, and steatosis due to increased hepatic de novo lipogenesis (Wang et al., 2015).